Aashka Hospitals Ltd Stock Price Today (NSE: AASHKA)
Fundamental Score
Aashka Hospitals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Aashka Hospitals Ltd share price today is ₹74.98, down 0.03% on NSE/BSE as of 2 June 2026. Aashka Hospitals Ltd (AASHKA) is a Small-cap company in the Hospital sector with a market capitalisation of ₹213.53 (Cr). The 52-week high for AASHKA share price is ₹105.50 and the 52-week low is ₹59.00. At a P/E ratio of 187.31x, AASHKA is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 2.39% and a debt-to-equity ratio of 0.13.
Aashka Hospitals Ltd Share Price Chart — NSE/BSE Historical Performance
Aashka Hospitals Ltd share price chart: 1.49% return over the past month. 52-week high ₹105.50, 52-week low ₹59.00.
Aashka Hospitals Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹75.00 | ₹75.00 | ₹75.00 | ₹75.00 | 1.00K (Cr) | |
| ₹82.00 | ₹82.00 | ₹69.01 | ₹78.37 | 9.00K (Cr) | |
| ₹73.00 | ₹78.50 | ₹73.00 | ₹73.50 | 10.00K (Cr) | |
| ₹68.00 | ₹81.00 | ₹68.00 | ₹79.50 | 14.00K (Cr) | |
| ₹77.00 | ₹78.00 | ₹77.00 | ₹77.50 | 2.00K (Cr) | |
| ₹77.00 | ₹77.00 | ₹77.00 | ₹77.00 | 1.00K (Cr) | |
| ₹83.75 | ₹83.99 | ₹77.00 | ₹77.00 | 27.00K (Cr) | |
| ₹76.00 | ₹81.00 | ₹76.00 | ₹81.00 | 16.00K (Cr) | |
| ₹73.45 | ₹74.00 | ₹66.00 | ₹73.51 | 71.00K (Cr) | |
| ₹73.50 | ₹73.55 | ₹73.50 | ₹73.55 | 39.00K (Cr) |
Aashka Hospitals Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹73.45 | ₹83.99 | ₹66.00 | ₹75.00 | +2.11% | |
| ₹59.00 | ₹73.90 | ₹59.00 | ₹73.55 | +24.66% | |
| ₹72.00 | ₹77.00 | ₹59.00 | ₹59.00 | -18.06% | |
| ₹65.50 | ₹80.00 | ₹65.50 | ₹77.00 | +17.56% | |
| ₹81.00 | ₹85.00 | ₹67.39 | ₹80.00 | -1.23% | |
| ₹91.25 | ₹92.00 | ₹74.01 | ₹81.00 | -11.23% | |
| ₹89.00 | ₹99.50 | ₹79.22 | ₹87.25 | -1.97% | |
| ₹73.40 | ₹94.00 | ₹65.10 | ₹89.00 | +21.25% | |
| ₹80.00 | ₹88.00 | ₹70.35 | ₹84.00 | +5.00% | |
| ₹86.50 | ₹88.50 | ₹76.05 | ₹80.00 | -7.51% | |
| ₹103.00 | ₹105.50 | ₹80.00 | ₹88.85 | -13.74% | |
| ₹88.15 | ₹104.25 | ₹88.15 | ₹103.00 | +16.85% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Aashka's a micro-cap hospital trading at nosebleed valuations with negative free cash flow — stay away.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Aashka Hospitals submitted a SEBI compliance certificate for Q4 FY26. The trading window closed for audited financial results for the half year and year ended March 31, 2026. As of April 15, 2026, Aashka Hospitals' share price was
CORE STORY (THE REAL GAME)
Aashka is a micro-cap hospital play, likely riding the broader India healthcare demand narrative. However, its valuation and recent performance raise concerns about whether the market's pricing in unsustainable optimism.
- Healthcare sector growth in India
- High promoter holding
- Debt reduction
- Significant order wins
- Successful expansion into new regions
- Turnaround in sales and profit growth
- Micro/SME cap - liquidity risk
- Expensive valuation P/E 187.31x vs Industry P/E 52.84x
- Negative free cash flow of ₹-42.68 Cr
No institutional holdings trend are available.
India's healthcare sector is growing, but Aashka's micro-cap status makes it vulnerable to broader market downturns.
No, Free Cash Flow 5Y: ₹-42.68 Cr
Aashka needs to demonstrate significant improvement in sales and profitability to justify its valuation. Without a turnaround, the stock is likely to underperform.
Primary Thesis Risk
Unsustainable valuation combined with poor financials and micro-cap illiquidity.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Aashka Hospitals Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Aashka Hospitals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AASHKA across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (19.07%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Conservative Debt Levels (D/E: 0.13)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (61.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (2.39%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.07%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 187.31x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-82.72%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-15.53%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-3.62% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (1.98x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-42.68 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Aashka Hospitals Ltd vs Hospital Peers
Peer Comparison - Hospital
Compare Aashka Hospitals Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Aashka Hospitals LtdAashka Hospital...Selected✓ AASHKA • 543346 | 20.8/100 | ₹74.98₹75 | ₹213.53₹213.53 | 187.31Average 187.3 Average | 2.39%Poor 2.39% Poor | 4.07%Poor 4.07% Poor | 0.13Excellent 0.1 Excellent | 11.14%Good 11.14% Good | -3.62%Poor -3.62% Poor | 0.00% |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 69.1/100 | ₹993.45₹993 | ₹109416.28₹109416.28 | 77.65Average 77.7 Average | 12.72%Average 12.72% Average | 14.88%Average 14.88% Average | 0.33Excellent 0.3 Excellent | 80.50%Excellent 80.50% Excellent | 46.01%Excellent 46.01% Excellent | 0.13% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 50.2/100 | ₹8272.50₹8273 | ₹104825.94₹104825.94 | 62.70Average 62.7 Average | 18.42%Good 18.42% Good | 16.64%Good 16.64% Good | 0.88Good 0.9 Good | 33.72%Excellent 33.72% Excellent | 14.15%Good 14.15% Good | 0.26% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 55.6/100 | ₹960.90₹961 | ₹68301.24₹68301.24 | 67.80Average 67.8 Average | 10.13%Average 10.13% Average | 11.96%Average 11.96% Average | 0.34Excellent 0.3 Excellent | 70.31%Excellent 70.31% Excellent | 10.93%Good 10.93% Good | 0.11% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 62.2/100 | ₹1920.20₹1920 | ₹39051.19₹39051.19 | 45.92Average 45.9 Average | 24.22%Excellent 24.22% Excellent | 20.75%Excellent 20.75% Excellent | 0.58Good 0.6 Good | 43.49%Excellent 43.49% Excellent | 11.88%Good 11.88% Good | 0.24% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 15.4/100 | ₹741.25₹741 | ₹34688.15₹34688.15 | 94.51Average 94.5 Average | 8.26%Poor 8.26% Poor | 10.68%Average 10.68% Average | 0.46Excellent 0.5 Excellent | -7.24%Poor -7.24% Poor | -13.71%Poor -13.71% Poor | 0.75% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 61/100 | ₹1207.80₹1208 | ₹33498.00₹33498.00 | 56.03Average 56.0 Average | 16.48%Good 16.48% Good | 19.74%Good 19.74% Good | 0.25Excellent 0.3 Excellent | 70.15%Excellent 70.15% Excellent | 19.73%Excellent 19.73% Excellent | 0.04% |
45.1/100 | ₹784.45₹784 | ₹27605.54₹27605.54 | 83.99Average 84.0 Average | 18.48%Good 18.48% Good | 15.00%Good 15.00% Good | 1.40Average 1.4 Average | 25.01%Excellent 25.01% Excellent | 22.01%Excellent 22.01% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 51.2/100 | ₹479.95₹480 | ₹16844.04₹16844.04 | 145.15Average 145.2 Average | 4.76%Poor 4.76% Poor | 9.99%Poor 9.99% Poor | 0.51Good 0.5 Good | 41.72%Excellent 41.72% Excellent | 26.38%Excellent 26.38% Excellent | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 54.6/100 | ₹1377.10₹1377 | ₹13410.38₹13410.38 | 52.84Average 52.8 Average | 17.43%Good 17.43% Good | 18.69%Good 18.69% Good | 0.54Good 0.5 Good | 33.66%Excellent 33.66% Excellent | 16.08%Excellent 16.08% Excellent | 0.23% |
36.4/100 | ₹659.95₹660 | ₹10474.40₹10474.40 | 296.22Average 296.2 Average | 5.14%Poor 5.14% Poor | 8.56%Poor 8.56% Poor | 1.92Average 1.9 Average | 19.34%Excellent 19.34% Excellent | 15.22%Excellent 15.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Max Healthcare Institute Ltd share price109416.28 Cr
- Apollo Hospitals Enterprise Ltd share price104825.94 Cr
- Fortis Healthcare Ltd share price68301.24 Cr
- Narayana Hrudayalaya Ltd share price39051.19 Cr
- Aster DM Healthcare Ltd share price34688.15 Cr
Aashka Hospitals Ltd PE Ratio History
Historical price-to-earnings ratio for AASHKA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹1.01 | ₹109.40 | 108.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Aashka Hospitals Ltd Quarterly Performance
Latest quarterly metrics for AASHKA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-15.53%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-82.72%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-3.62%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
11.14%
Compounded annual net profit growth over 5 years
Aashka Hospitals Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AASHKA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Aashka Hospitals Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Aashka Hospitals Ltd (AASHKA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Aashka Hospitals Ltd
About AASHKA (Aashka Hospitals Ltd)
Aashka Hospitals Ltd is a beacon of advanced medical care, standing as a multi-specialty institution dedicated to healing and wellness. The hospital complex is a modern architectur...al marvel, designed to provide a serene and comforting environment for patients and their families. Within its walls, state-of-the-art technology seamlessly integrates with compassionate care, offering a holistic approach to treatment. From the welcoming reception area bathed in natural light to the meticulously designed patient rooms, every detail is curated to foster recovery and well-being. Aashka Hospitals strives to be more than just a healthcare provider; it aspires to be a trusted partner in every individual's journey to better health. Aashka Hospitals boasts a wide range of specialized departments, each staffed by leading experts in their respective fields. Patients can access a comprehensive suite of services, including advanced diagnostics, cutting-edge surgical procedures, and personalized treatment plans. The hospital is particularly renowned for its excellence in critical care, cardiac sciences, and neurological disorders, offering round-the-clock emergency services and specialized intensive care units. Beyond medical intervention, Aashka Hospitals emphasizes preventive care and health education, empowering individuals to take proactive steps towards maintaining their well-being. The institution believes in a collaborative approach, fostering open communication between patients, families, and healthcare professionals to ensure the best possible outcomes. Aashka Hospitals is committed to innovation and continuous improvement, constantly seeking new ways to enhance the quality and accessibility of healthcare. The hospital invests heavily in research and development, partnering with leading institutions to explore new treatments and technologies. Moreover, Aashka Hospitals is deeply rooted in the community, actively participating in outreach programs and initiatives aimed at promoting public health. With a strong emphasis on ethical practices and patient-centric care, Aashka Hospitals strives to set a new standard of excellence in the healthcare industry, providing hope and healing to all those who seek its services.
Company Details
Key Leadership
Latest News
AASHKA Share Price: Frequently Asked Questions
What is the current share price of Aashka Hospitals Ltd?
Aashka Hospitals Ltd (AASHKA) trades at ₹74.98 on NSE and BSE. Market cap ₹213.53 (Cr). Educational data only.
What is the P/E ratio of Aashka Hospitals Ltd?
Aashka Hospitals Ltd has a P/E of 187.31x vs industry average 52.84x.
What is the Bull Run score for Aashka Hospitals Ltd?
Aashka Hospitals Ltd has a Bull Run score of 20.8/100 based on 25+ financial parameters.
Does Aashka Hospitals Ltd pay dividends?
Aashka Hospitals Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Aashka Hospitals Ltd?
Aashka Hospitals Ltd has ROE of 2.39%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Aashka Hospitals Ltd?
Aashka Hospitals Ltd has debt-to-equity of 0.13.
Is Aashka Hospitals Ltd a good investment?
Bull Run gives Aashka Hospitals Ltd a score of 20.8/100. This is not investment advice — consult a SEBI-registered advisor.